Business
LifeMine Raises $263M to Mine Fungi for a Safer Organ-Transplant Drug
Backed by Bezos and Gates funds, the company’s fungal-genome platform yielded LIFE-001, a long-acting drug that suppresses transplant rejection while sparing the brain.